What is the management approach for a patient with a zolpidem (Ambien) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Zolpidem Overdose

Zolpidem overdose is generally benign when taken alone and requires primarily supportive care with airway management, though co-ingestion with other CNS depressants significantly increases risk of respiratory compromise and ICU admission. 1, 2

Immediate Assessment and Stabilization

Clinical Presentation

  • Isolated zolpidem overdose typically presents with somnolence to coma, with doses up to 600 mg (60 times therapeutic dose) causing only mild-to-moderate symptoms in most patients 2, 3
  • Combined ingestions with alcohol, benzodiazepines, or other psychotropic medications can cause coma at doses as low as 100-150 mg and dramatically increase morbidity 4, 3
  • Serious manifestations include impaired consciousness, cardiovascular compromise, respiratory depression, and pulmonary edema in severe cases 1, 5
  • Rare cardiac complications such as atrial fibrillation may occur in patients with underlying cardiomyopathy 6

Initial Management Steps

  • Monitor vital signs continuously: respiration, pulse, blood pressure, and oxygen saturation 1
  • Secure airway and provide respiratory support as needed—this is the primary life-threatening concern 1
  • Administer intravenous fluids as clinically indicated 1
  • Perform gastric lavage when appropriate (if presentation is within 1-2 hours of ingestion) 1

Antidote Consideration: Flumazenil

Flumazenil is effective in reversing zolpidem-induced sedation but should be used selectively due to seizure risk. 1, 3

When to Use Flumazenil

  • Flumazenil reduces zolpidem's sedative-hypnotic effects and can successfully reverse disturbances of consciousness in both mono- and combined intoxications 1, 3
  • Dosing: 0.01-0.02 mg/kg IV (maximum 0.2 mg initially), repeat at 1-minute intervals to maximum cumulative dose of 0.05 mg/kg or 1 mg total 7

Critical Contraindications and Warnings

  • Do NOT use flumazenil if tricyclic antidepressant co-ingestion is suspected—may precipitate seizures or arrhythmias 7
  • Use extreme caution in patients with underlying seizure disorders or chronic benzodiazepine use—may precipitate withdrawal seizures 7, 1
  • Flumazenil may contribute to neurological symptoms including convulsions 1
  • Duration of flumazenil is shorter than zolpidem; observe continuously for at least 2 hours after last dose and be prepared for re-sedation 7

Disposition and Monitoring

Admission Criteria

  • ICU admission is frequently required when zolpidem is co-ingested with over-the-counter medications (OR 3.33), other psychotropic drugs (OR 3.11), or alcohol (OR 2.12) 4
  • In one series, 44% of ED patients required ICU admission, with only 17% discharged home 4
  • Monitor for approximately 24 hours in combined intoxications, even if initial presentation appears mild 3

Expected Clinical Course

  • Symptoms typically remit rapidly in 91% of isolated zolpidem overdoses 2
  • Recovery is generally complete with supportive care alone 2, 3

Key Clinical Pitfalls to Avoid

  • Do not assume benign course with co-ingestions: Even low zolpidem doses (100-150 mg) can cause coma when combined with other CNS depressants 3
  • Do not withhold sedating drugs if excitation occurs following overdose—this paradoxical reaction requires careful management 1
  • Do not rely on dialysis: Zolpidem is not dialyzable and hemodialysis is ineffective 1
  • Always consider multiple drug ingestion and contact poison control for up-to-date management guidance 1
  • Avoid co-prescribing opioids and zolpidem: This combination carries 3-10 fold increased mortality risk 7

Specific Monitoring Parameters

  • Cardiovascular: Monitor for hypotension, arrhythmias (especially atrial fibrillation in patients with cardiomyopathy) 1, 6
  • Respiratory: Watch for respiratory depression and pulmonary edema 1, 5
  • Neurological: Assess level of consciousness, watch for seizures if flumazenil administered 1
  • Duration: Symptoms in isolated overdose resolve quickly, but combined ingestions require extended observation 2, 3

References

Research

Acute zolpidem poisoning--analysis of 344 cases.

Journal of toxicology. Clinical toxicology, 1994

Research

[Acute overdose of Zolpidem (Stilnox)].

Schweizerische medizinische Wochenschrift, 1996

Research

Acute zolpidem overdose--report of two cases.

Journal of analytical toxicology, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.